NCT02784795 2025-08-21A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Terminated94 enrolled 28 charts
NCT02079636 2020-09-11A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 1 Completed142 enrolled 36 charts